Product Information
LORYNA 3 MG-0.02 MG TABLET is a generic product labeled by Xiromed LLC, priced at $0.1895 per EA under NDC 70700011485. Its NADAC has been published 411 times since Aug 15, 2018.
Manufacturer
Xiromed LLCNDC
70700011485
Classification
Generic
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA079221On Market Since
6/9/2022
Price Statistics
The NADAC for LORYNA 3 MG-0.02 MG TABLET has been published 411 times since Aug 15, 2018, and over the history we have for it it has declined 72.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1895 per EA |
|---|---|
| All-time high | $0.6994 (Aug 15, 2018) |
| All-time low | $0.1278 (Nov 20, 2024) |
| 52-week high | $0.1895 |
| 52-week low | $0.1538 |
| Median price | $0.3346 |
| Average price | $0.3189 |
| Largest weekly change | -32.1% (Nov 20, 2024) |
| Weeks tracked | 411 |
| Tracking since | Aug 15, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Drospirenone and Ethinyl Estradiol Tablets market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of LORYNA 3 MG-0.02 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LORYNA 3 MG-0.02 MG TABLET, manufactured by Xiromed LLC, is $0.1895 per EA (NDC 70700011485), effective Jun 24, 2026.
How has the price of LORYNA 3 MG-0.02 MG TABLET changed over time?
Over the history we have for it, the NADAC for LORYNA 3 MG-0.02 MG TABLET has declined 72.9%. It has been tracked across 411 weekly CMS publications since Aug 15, 2018.
What are the highest and lowest recorded NADAC prices for LORYNA 3 MG-0.02 MG TABLET?
Since Aug 15, 2018, the NADAC for LORYNA 3 MG-0.02 MG TABLET has ranged from a low of $0.1278 (Nov 20, 2024) to a high of $0.6994 (Aug 15, 2018), with a median of $0.3346 per EA.
Are there cheaper alternatives to LORYNA 3 MG-0.02 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of LORYNA 3 MG-0.02 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures LORYNA 3 MG-0.02 MG TABLET?
LORYNA 3 MG-0.02 MG TABLET (NDC 70700011485) is labeled by Xiromed LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification